Stephanie Vargas Esquivel

Ms. Stephanie Vargas Esquivel

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
SEStephanie Vargas Esquivel
Stephanie Vargas Esquivel
HBHimanshu N. Bhatt
Himanshu N. Bhatt
RDRimpy Diwan
Rimpy Diwan
Ahsan HabibAhsan Habib
Ahsan Habib
WLWen-Yee Lee
Wen-Yee Lee
MNMd Nurunnabi
Md Nurunnabi
The oral route is considered the most convenient route of drug administration for both systemic and local delivery. Besides stability and transportation, another unmet but important issue regarding oral medication is retention duration within the specific region of the gastrointestinal (GI) tract. We hypothesize that an oral vehicle that can adhere and maintain retention within the stomach for a longer duration can be more effective to treat stomach-related diseases. Therefore, in this project, we developed a carrier that is highly specific to the stomach and maintains its retention for a longer duration. We developed a vehicle composed of β-Glucan And Docosahexaenoic Acid (GADA) to observe its affinity and specificity to the stomach. GADA forms a spherical-shaped particle with negative zeta potential values that vary based on the feed ratio of docosahexaenoic acid. Docosahexaenoic acid is an omega-3 fatty acid that has transporters and receptors throughout the GI tract, such as CD36, plasma membrane-associated fatty acid-binding protein (FABP (pm)), and a family of fatty acid transport proteins (FATP1-6). The in vitro studies and characterization data showed that GADA has the capability to carry a payload of hydrophobic molecules and specifically deliver the payload to the GI tract, exert its therapeutic effects, and help to maintain stability for more than 12 h in the gastric and intestinal fluid. The particle size and surface plasmon resonance (SPR) data showed that GADA has a strong binding affinity with mucin in the presence of simulated gastric fluids. We observed a comparatively higher drug release of lidocaine in gastric juice than that in intestinal fluids, demonstrating the influence of the pH values of the media on drug-release kinetics. In vivo and ex vivo imaging of mice demonstrated that GADA maintains its retention within the stomach for at least 4 hr. This stomach-specific oral vehicle holds strong promise to translate various injectable therapeutic drugs to oral form upon further optimizations.

12 October 2026 in Advanced Engineering Materials
Verified
Journal Article
Open access
PDF file
SEStephanie Vargas Esquivel
Stephanie Vargas Esquivel
ARAaron Rodriguez
Aaron Rodriguez
AMAsahel Marinelarena‐Diaz
Asahel Marinelarena‐Diaz
YZYuwei Zong
Yuwei Zong
XYXingyue Yang
Xingyue Yang
AMAnabel Renteria Marquez
Anabel Renteria Marquez
Tactile biosensors areimportant for biomedical applications that require sensing mechanical stimuli like pressure, strain, and vibration. This review considers developments in tactile biosensor designs through additive manufacturing (AM) and machine learning (ML). The review defines four sensor mechanisms, piezoelectric, piezoresistive, strain gauge, and capacitive, and summarizes their working principles, materials, and biomedical relevance. Various additive manufacturing methods, such as direct ink writing, fused deposition modeling, stereolithography, and selective laser sintering, are discussed for their properties that provide customization, multimaterial, and sensor sensitivity improvements. Signal‐acquisition and processing strategies are also reviewed, as well as ML algorithms for classification and design optimization. Finally, this review paper indicates current obstacles for commercialization, for example, limitations of materials, variability of performance, or lack of scaling up for manufacturing. Tactile biosensor applications in biomedical engineering will continue to merge materials science, AM, and, in some contexts, data‐driven methods to provide the next evolution of biosensors that will offer reliable, accessible, and functional biosensors.